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ABSTRACT: Two classes of iodine-rich salts that consist of
iodine-rich cations and iodate (IO3
−) or periodate (IO4
−)
anions were synthesized. The synthesis of analogous I3O8
−
salts was more diﬃcult because of poor solubility and
hydrolytic instability. All iodine-rich salts were fully charac-
terized by infrared, 1H nuclear magnetic resonance, and 13C
nuclear magnetic resonance spectroscopy as well as elemental
analyses. The molecular structures of compounds 15 and 24
were elucidated by X-ray single-crystal diﬀraction. Additionally,
the heats of formation were calculated with Gaussian 03. The
detonation properties and biocidal eﬃciency were calculated
and evaluated using CHEETAH 7.
■ INTRODUCTION
To defeat a biological weapon eﬀectively, it is necessary not
only to eliminate the weapon of mass destruction (WMD) in
the target but also to ensure that there are no viable biological
agents in the plume that may cause collateral damage when
released upon destruction of the target. The explosion of
conventional warheads generates transient thermal eﬀects that
have a limited destructive impact on biological agents, and the
blast could also have the undesirable eﬀect of airborne dispersal
of those biological agents. Therefore, in recent years, agent
defeat weapons (ADWs) were developed to destroy or
neutralize the active agents in the plume by releasing large
amounts of strong biocides upon detonation.1 Iodine is an
eﬀective biocide; the destruction of certain bacteria, amoebic
cysts, and viruses (a 99.999% kill in 10 min at 25 °C) may
require I2 residuals of 0.2, 3.5, and 14.6 ppm, respectively.
2
However, because of the ready sublimation of iodine, it is not
practical to use the element itself as an ingredient in ADWs.
Iodine-rich compounds in which the iodine exists in the form of
C−I, iodide, or iodate exhibit relatively better stability and,
therefore, could be used as potential ingredients for ADWs.






trimethylammonium)ethyl]amine tripentaiodide4 or molecular
species such as 4,5-diiodo-1H-1,2,3-triazole,5 tetraiodofuran,6
and 1-diiodomethyl-3,4,5-triodopyrazole7 were developed as
potential ingredient candidates for ADWs (Figure 1). They are
materials that produce nearly quantitative amounts of gaseous
iodine (I2) upon decomposition when formulated with
oxidizers such as I2O5, HI3O8, HIO3, and other components,
but I2O5 and HI3O8 are hygroscopic and sensitive to moisture,
making them readily hydrolyzable forming HIO3 even under
low-humidity conditions.8
Because energetic salts have the advantage of no or low vapor
pressure, high thermal stability, and density and cations act as
fuels while anions play a role as oxidizers in most cases,9 the




as an anion in a prospective biocide should ensure a high iodine
content and improve the oxygen balance, as well. This type of
iodine-rich salt would provide an oxygen balance that
approaches zero; therefore, these materials upon decomposi-
tion may ﬁnd application as single-based biocidal agents.
We now describe a series of compounds comprised of an
iodine-rich imidazolium cation and an iodate or periodate anion
whose structures have been fully determined and whose
properties have been investigated. Our eﬀorts to synthesize
iodine-rich imidazolium I3O8
− compounds failed because of the
poor solubility of I3O8
− in organic solvents as well as their
hydrolytic sensitivity.
■ RESULTS AND DISCUSSION
Synthesis. Imidazolium cations have been studied exten-
sively in the ﬁeld of ionic liquids.10 They can be prepared
readily by the reaction of an N-alkylimidazole with alkyl halide.
To achieve a high iodine content and good oxygen balance, our
ﬁrst attempt was to prepare the 1,3-dimethyl-2,4,5-triiodoimi-
dazolium cation by reacting 1-methyl-2,4,5-triiodoimidazole5
with iodomethane. However, a mixture of compounds 2 and 3
(4:1 ratio) was obtained on the basis of proton nuclear
magnetic resonance (NMR) integration (Scheme 1) probably
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because of the electron donating eﬀect of the methyl groups
that cause the C−I in position 2 to be a very good leaving
group. When 1-methyl-4,5-diiodoimidazole was used as the
starting material, the reaction with iodomethane under similar
reaction conditions gives 3 as a single product in good purity
(Scheme 2).
The introduction of methylene and ethylene bridges has the
advantage of improving the thermal stability;11 therefore,
methylene- and ethylene-bridged 4,5-diioimidazole cations (6
and 7, respectively) were prepared by reacting 4,5-diiodoimi-
dazole with KOH and diiodomethane or 1,2-dibromoethane in
DMF in the presence of tetraethylammonium bromide as a
phase transfer catalyst, followed by the reaction with iodo-
methane (Scheme 3).
To improve the energy content, cations containing one or
two N-NH2 groups (9 and 12, respectively) were prepared on
the basis of a procedure similar to that described in the
literature.12 1-Methyl-4,5-diiodoimidazole or 1-amino-4,5-diio-
doimidazole in acetonitrile was treated with freshly prepared O-
tosylhydroxylamine in dichloromethane to precipitate the
corresponding tosylate salt. The tosylate salt reacts with a
stoichiometric amount of aqueous hydrobromic acid, resulting
in the bromide salt (Schemes 4 and 5). The amination of
compounds 4 and 5 failed because of their poor solubility in
acetonitrile, which precluded the reaction with O-tosylhydroxyl-
amine.
Silver iodate, AgIO3, or silver periodate, AgIO4, was readily
prepared by treating NaIO3 or NaIO4, respectively, with
AgNO3 in aqueous solution; AgI3O8 was prepared according to
the literature method.13 With the pure iodine-rich imidazolium
iodide or bromide and AgIO3 or AgIO4 materials available, the
iodine-rich salts (14−23) were easily prepared via metathesis
reactions of the corresponding iodide or bromide compounds
with AgIO3 or AgIO4 in aqueous solution at 50 °C for 1 h. The
solid AgI was removed by ﬁltration, and the water in the ﬁltrate
was removed under vacuum to produce the desired compounds
(Scheme 6). To prepare compound 13, a mixture of
compounds 13 and 14 was obtained initially by reacting the
mixture of 2 and 3 with AgIO3. The mixed products were
washed with water to leave a solid residue that was found to be
pure 13 in low yield (32.4%). The reaction of 9 with AgI3O8 in
water results in compound 24 as a hydrolysis product; its
structure was conﬁrmed by X-ray single-crystal diﬀraction
(Figure S4).
Spectroscopy. All NMR spectra were recorded in dimethyl
sulfoxide-d6 (DMSO-d6). NMR data for compounds 13 and 21
could not be obtained because of their poor solubility in
DMSO. Compounds with the same cation exhibit almost the
same chemical shifts in the spectra. In the 1H NMR spectra for
the imidazole ring, CH is found at δ 9.42−9.92 (s), the amino
group at δ 6.73−6.79 (s), and the methyl group at 3.79−3.92
(s). In the 13C NMR spectra, the resonance for CH appears at δ
∼142 (s) and the chemical shift for C−I is at δ ∼95.
X-ray Crystallography. Suitable crystals of 15 for single-
crystal X-ray diﬀraction were grown from water; three water
molecules of crystallization are present in the crystal structure
(Figure 2). The crystallographic data and reﬁnement details as
well as the packing diagrams are listed in the Supporting
Information. The torsion angles [I1−C3−C4−N1 =
−178.6(3)°, N2−C3−C4−I2 = 174.5(3)°, C5−N3−C7−I3 =
−179.2(3)°, and I4− C6−C7−N3 = −173.2(3)°] show that
the C−I bond is almost planar with the imidazole ring. The O4
atom in an anion forms two hydrogen bonds with the CH
moieties in each of the two imidazole rings as shown in Figure
2.
Physicochemical Properties. The thermal behavior of
compounds 13−23 was investigated by performing diﬀerential
scanning calorimeter scans at a heating rate of 5 °C/min.
Densities were obtained at 25 °C using a gas pycnometer. All
compounds decompose without melting in the range from 92.3
°C (20) to 187.0 °C (14). Densities range between 2.86 g cm−3
(21) and 3.20 g cm−3 (18). The replacement of a methyl group
with an amino group leads to an increase in density. The IO4
Figure 1. Promising iodine-rich ADW ingredients.
Scheme 1. Quaternization of 1
Scheme 2. Synthesis of Compound 3
Scheme 3. Preparation and Quaternization of Methylene- and Ethylene-Bridged 4,5-Diiodoimidazoles
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anion-containing compounds are slightly less dense than their
IO3 analogues.
The heats of formation of all the compounds were calculated
using the Gaussian 03 (revision E.01) suite by isodesmic
reactions.14 For iodine-rich cations, the (15s, 11p, 6d) basis of
Stromberg et al.15 was augmented with another p shell and the
ﬁve valence sp exponents were optimized, resulting in a
[5211111111, 411111111, 3111] contraction scheme in
conjunction with 6-31+G** for ﬁrst- and second-row elements.
Single-point energy (SPE) reﬁnement on the optimized
geometries was performed with the use of the MP2/6-311+
+G** level. The heats of formation for the IO3
− and IO4
−
anions were obtained by using the G2ECP (ZPE=MP2)
method. The heats of formation for the salts were calculated by
employing the Born−Haber cycle. Heats of formation for
compounds 13−23 are in the range from −1412.3 kJ mol−1
(21) to −24.7 kJ mol−1 (18). The presence of additional amino
groups in the molecules results in higher heats of formation.
The composition of the decomposition products for the
iodine-rich compounds is an important parameter in evaluating
their ability to destroy or neutralize an active agent. The higher
the iodine (I2) concentration in the products generated, the
more eﬃcient the compound is as a biocide. The decom-
position products were predicted using CHEETAH 7 under
Chapman−Jouguet conditions. The products were converted to
standard atmospheric conditions at 298 K and 1 atm (Table 1).
As shown in Figure 3, most of the compounds release more
than 70 wt % of I2 upon decomposition. Compound 13 exhibits
Scheme 4. Preparation of 1-Amino-3-methyl-4,5-diiodoimidazolium Bromide (9)
Scheme 5. Synthesis of 1,3-Diamino-4,5-diiodoimidazolium Bromide (12)
Scheme 6. Preparation of Salts with IO3
− or IO4
− Anions via Metathesis Reactions
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the best biocidal capability. The IO3
−-containing compounds
show biocidal activity that is more promising than that of the
corresponding IO4
−-containing compounds upon decomposi-
tion.
Detonation velocities and pressures were calculated with the
CHEETAH 7 code. All of the iodine-rich iodate and periodate
salts exhibit low detonation properties (Table 2). Compound
18 possesses the best detonation properties (D = 4558 m s−1; P
= 13.79 GPa) among the new iodo compounds. The impact
sensitivities are found to be in the range of 3−6 J, which is
comparable with that of the IO2-substituted compounds we
reported previously.5 While improved iodine content for
compounds 13−23 ranging from 70.3 to 78.1% was observed,
the oxygen balances are from −4.4 to −16.8%; their high iodine
content and good oxygen balance give rise to good candidates
for use as single-based biocidal agents.
■ CONCLUSIONS
In conclusion, a series of compounds consisting of iodine-rich
imidazolium cations and IO3
− or IO4
− anions were prepared
and fully characterized. The structure of compound 15 was
determined by single-crystal X-ray diﬀraction. All of the
compounds have high densities, high iodine contents, desirable
detonation properties, and acceptable oxygen balances that
make them good candidates as single-based biocidal agents. To
achieve desirable impact sensitivities, the treatment with
coating agents will be needed for their future applications.
■ EXPERIMENTAL SECTION
Caution: All of the oxyiodate salts presented in this paper are sensitive to
impact and may explode under certain conditions. Appropriate safety
precautions should be taken when preparing and handling them.
General Methods. Reagents were purchased from Aldrich and
Acros Organics and used as received. 1H and 13C NMR spectra were
recorded on a 300 MHz (Bruker AVANCE 300) nuclear magnetic
resonance spectrometer operating at 300.13 and 75.48 MHz,
respectively. DMSO-d6 was used as a solvent and locking solvent.
Chemical shifts in the 13C spectra are reported relative to Me4Si. The
melting and decomposition points were obtained on a diﬀerential
scanning calorimeter (TA Instruments Co., model Q20) at a heating
rate of 5 °C/min. IR spectra were recorded using KBr pellets for solids
on a Bio-Rad model 3000 FTS spectrometer. Densities were
determined at 25 °C by employing a Micromeritics AccuPyc 1330
gas pycnometer. Elemental analyses were conducted using an Exeter
Figure 2. Crystal structure of 15·3H2O.
Table 1. Predicted Major Decomposition Products with
CHEETAH 7
compd N2(g) I2(g) HI(g) C(s) CH4(g) CO2(g)
13 4.31 77.14 0.10 3.73 3.67 10.14
14 5.35 71.59 1.10 4.05 5.32 12.58
15 5.43 72.81 1.00 4.11 3.85 12.78
16 5.36 71.78 1.05 4.63 4.56 12.60
17 8.01 71.48 1.07 2.33 4.54 12.56
18 10.66 71.38 1.03 0.60 3.77 12.53
19 5.19 69.44 1.09 2.82 5.16 16.28
20 5.27 70.60 1.00 2.86 3.73 16.53
21 5.20 69.62 1.04 3.38 4.42 16.31
22 7.77 69.35 1.06 1.15 4.41 16.25
23 10.34 67.76 2.52 0 3.29 15.34
Figure 3. Sum of I2 and HI in the decomposition products (weight percent).
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CE-440 elemental analyzer. Impact sensitivity measurements were
taken using a standard BAM Fallhammer.
Iodination of 1-Methyl-2,4,5-triiodoimidazole. To a solution
of 1-methyl-2,4,5-triiodoimidazole (0.92 g, 2 mmol) in DMF (5 mL)
was added iodomethane (0.34 g, 2.4 mmol) dropwise. The mixture
was stirred at 50 °C for 4 h. The solid formed was collected by
ﬁltration and washed with ethanol (3 × 5 mL) and then cold water (5
mL), resulting in a mixture of compounds 2 and 3 (0.81 g). Because
they are poorly soluble in organic solvents, separation was not
possible. The 2:3 ratio was 4:1 on the basis of proton NMR
integration.
1,3-Dimethyl-4,5-imidazolium Iodide (3). Pure 3 was prepared
as follows. To a suspension of 4,5-diiodoimidazole (0.96 g, 3 mmol)
and potassium carbonate (0.56 g, 4 mmol) in DMF (10 mL) was
slowly added iodomethane (1.28 g, 9 mmol). The reaction mixture
was stirred at 50 °C overnight. The precipitate was ﬁltered and washed
with ethanol (3 × 5 mL) and diethyl ether (5 mL). Yield: 0.89 g,
62.4%. Tdec: 252.4 °C. IR: ν = 3106, 3018, 2939, 1652, 1553, 1489,
1433, 1235, 1204, 1192, 1166, 1101, 1084, 942, 829, 800, 771, 698,
655, 611 cm−1. 1H NMR (DMSO-d6): δ 9.42 (1H, s, CH), 3.83 (6H, s,
CH3).
13C NMR (DMSO-d6): δ 38.82, 94.03, 140.75. Elemental
analysis of C5H7I3N2 (475.83). Calcd: C, 12.62; H, 1.48; N, 5.89.
Found: C, 12.66; H, 1.27; N, 5.72.
Bis(4,5-diiodo-1H-imidazol-1-yl)methane (4). A mixture of 4,5-
diiodoimidazole (1.6 g, 5 mmol) and potassium hydroxide (0.28 g, 5
mmol) in DMF (4 mL) was stirred at room temperature for 30 min.
Tetraethylammonium bromide (TEAB) (0.12 g) was added, followed
by diiodomethane (0.67 g, 2.5 mmol). The reaction mixture was
heated for 10 h at 50 °C, cooled to room temperature, and poured into
cold water (10 mL). The resulting precipitate was collected by
ﬁltration and washed with water (3 × 5 mL) and ethanol (3 × 3 mL).
Air drying gave a pale yellow solid. Yield: 1.42 g, 87.4%. Tdec: 252.4 °C.
IR: ν = 3101, 1629, 1483, 1443, 1391, 1347, 1311, 1225, 1153, 1072,
977, 937, 814, 775, 752, 652, 610, 440 cm−1. 1H NMR (DMSO-d6): δ
8.07 (2H, s, CH), 6.24 (2H, s, CH2).
13C NMR (DMSO-d6): δ 59.8,
84.2, 98.6, 143.4. Elemental analysis of C7H4I4N4 (651.75). Calcd: C,
12.90; H, 0.62; N, 8.60. Found: C, 12.92; H, 0.59; N, 8.40.
Bis(4,5-diiodo-1H-imidazol-1-yl)ethane (5). A method similar
to that for 4 was used. Yield: 1.42 g, 85.3%. Tdec: 285.4 °C. IR: ν =
3101, 2959, 2778, 1639, 1541, 1479, 1470, 1425, 1375, 1285, 1270,
1229, 1203, 1179, 1163, 1142, 1074, 955, 937, 878, 818, 654, 617, 563,
446 cm−1. 1H NMR (DMSO-d6): δ 7.62 (2H, s, CH), 4.34 (4H, s,
CH2CH2).
13C NMR (DMSO-d6): δ 48.8, 85.8, 96.5, 141.9. Elemental
analysis of C8H6I4N4 (665.78). Calcd: C, 14.43; H, 0.91; N, 8.42.
Found: C, 14.60; H, 0.92; N, 8.19.
1,1′-Methylenebis(4,5-diiodo-3-methyl-1H-imidazolium)
Diiodide (6). To a 50 mL round bottom ﬂask containing bis(4,5-
diiodo-1H-imidazol-1-yl)methane (0.65g, 1 mmol) suspended in DMF
(2 mL) was added iodomethane (0.42 g, 3 mmol). The ﬂask was
sealed with a stopper and then heated slowly to 50 °C overnight. After
cooling to room temperature, the solid was collected by ﬁltration,
washed with methanol (3 × 3 mL), and air-dried. Yield: 0.73 g, 76.8%.
Tdec: 255.6 °C. IR: ν = 3026, 2984, 2927, 1655, 1546, 1499, 1437,
1391, 1359, 1309, 1182, 1094, 1043, 826, 792, 689, 629, 604, 490
cm−1. 1H NMR (DMSO-d6): δ 9.65 (2H, s, CH), 6.56 (2H, s, CH2),
3.91 (6H, s, CH3).
13C NMR (DMSO-d6): δ 63.94, 94.0, 97.1, 142.1.
Elemental analysis of C9H10I6N4 (935.63). Calcd: C, 11.55; H, 1.08; N,
5.99. Found: C, 11.55; H, 1.20; N, 5.99.
1,1′-Ethylenebis(4,5-diiodo-3-methyl-1H-imidazolium) Diio-
dide (7). A method similar to that for 6 was used. Yield: 0.68 g, 71.6%.
Tdec: 266.2 °C. IR: ν = 3126, 3077, 3006, 2889, 2082, 1653, 1553,
1532, 1503, 1438, 1390, 1361, 1324, 1297, 1195, 1180, 1151, 1102,
1070, 943, 769, 614 cm−1. 1H NMR (DMSO-d6): δ 9.68 (2H, s, CH),
4.63 (4H, s, CH2CH2), 3.86 (6H, s, CH3).
13C NMR (DMSO-d6): δ
39.45, 50.96, 95.84, 141.04. Elemental analysis of C10H12I6N4
(949.65). Calcd: C, 12.65; H, 1.27; N, 5.90. Found: C, 12.86; H,
1.24; N, 5.89.
1-Methyl-3-amino-4,5-diiodoimidazolium Bromide (9). To a
solution of 1-methyl-4,5-diiodoimiazole (0.67 g, 2 mmol) in
acetonitrile (8 mL) was added freshly prepared O-tosylhydroxylamine
(2.2 mmol) in dichloromethane (10 mL) while the mixture was being
stirred at room temperature. Stirring was continued for 8 h. The
precipitate was ﬁltered, air-dried, and then dissolved in a minimal
amount of ethanol. Hydrobromic acid (47%, 0.40 g) was added. After
the mixture had been stirred for 30 min, diethyl ether (60 mL) was
added. The resulting solid was ﬁltered and air-dried to yield 0.45 g
(52.3%) of 9. Tdec: 221.0 °C. IR: ν = 3265, 3184, 3102, 3052, 1610,
1538, 1499, 1432, 1395, 1192, 1174, 1115, 1106, 1083, 995, 806, 778,
606, 536 cm−1. 1H NMR (DMSO-d6): δ 9.46 (1H, s, CH), 6.78 (2H, s,
-NH2), 3.79 (3H, s, CH3).
13C NMR (DMSO-d6): δ 57.35, 93.90,
99.41, 141.21. Elemental analysis of C4H6BrI2N3 (429.82). Calcd: C,
11.18; H, 1.41; N, 9.78. Found: C, 11.68; H, 1.30; N, 9.60.
1,3-Diamino-4,5-diiodoimidazolium Bromide (12). To sodium
hydroxide (0.08 g, 2 mmol) in acetonitrile (8 mL) was added 4,5-
diiodoimidazole (0.64 g, 2 mmol). The mixture was stirred for 30 min
at room temperature, and freshly prepared O-tosylhydroxylamine (2.2
mmol) in dichloromethane (8 mL) was added slowly. The mixture was
stirred for 3 h at room temperature, followed by adding a second
equivalent of O-tosylhydroxylamine (2.2 mmol) in dichloromethane
(8 mL). The mixture was stirred for 8 h. The resulting solid was
ﬁltered, air-dried, and then dissolved in a minimal amount of ethanol,
followed by the addition of hydrobromic acid (47%, 0.40 g). After the
mixture had been stirred for 30 min, diethyl ether (60 mL) was added,
and the formed solid was ﬁltered and air-dried to yield 0.25 g (35.2%)
of 12. Tdec: 199.7 °C. IR: ν = 3249, 3111, 3064, 3004, 1636, 1526,
1416, 1351, 1274, 1201, 1176, 1069, 1022, 836, 784, 598, 565, 416
cm−1. 1H NMR (DMSO-d6): δ 9.54 (1H, s, CH), 6.74 (2H, s, -NH2).
13C NMR (DMSO-d6): δ 95.34, 134.72. Elemental analysis of
Table 2. Physicochemical Properties of Compounds 13−23
compd Td
a (°C) db (g/cm3) ΔHf°c (kJ/mol) Dd (m/s) Pe (Gpa) % iodine OBf (%) ISg (J)
13 177.4 3.17 −232.3 3173 6.0 78.1 −12 5
14 187.0 2.96 −300.1 3532 7.0 72.7 −17 6
15 124.7 2.96 −704.0 3166 5.4 73.8 −12 6
16 164.0 2.93 −749.8 3199 5.4 72.8 −15 6
17 148.4 3.12 −164.6 4132 10.4 72.5 −12 4
18 149.0 3.20 −24.7 4558 13.8 72.4 −8 4
19 130.4 2.92 −634.8 3383 5.8 70.5 −13 4
20 92.3 2.91 −1378.2 2958 4.2 71.6 −9 5
21 109.8 2.86 −1412.3 2959 4.1 70.6 −12 5
22 130.5 2.98 −495.4 3877 8.4 70.4 −9 3
23 143.1 3.03 −354.4 3433 11.1 70.3 −4 3
TNT 295 1.65 −31.7 6881 19.5 0 −25 15
aDecomposition temperature (onset). bMeasured density at 25 °C. cCalculated heat of formation. dDetonation velocity calculated with CHEETAH
7. eDetonation pressure calculated with CHEETAH 7. fOxygen balance for CaHbOcNdIe: OB = 1600(c − b/2 − a)/MW.
gImpact sensitivity
measured via the BAM method.
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C4H5BrI2N4 (430.81). Calcd: C, 8.36; H, 1.17; N, 13.00. Found: C,
8.29; H, 1.06; N, 11.86.
General Procedure for Preparing Imidazolium Iodate and
Periodate Salts. The iodide or bromide salt (0.2 mmol) was
suspended in water (5 mL), and AgIO3 or AgIO4 (0.4 mmol) was
added. The reaction mixture was protected from light and stirred at 50
°C for 3 h. The precipitate was removed by ﬁltration, and the product
was obtained by removing solvent and drying under vacuum. The
AgIO3 or AgIO4 was prepared by reacting the corresponding sodium
salt with AgNO3. For compound 13, a mixture of compound 2 and 3
was reacted with AgIO3. After the reaction, the solid mixture obtained
from the ﬁltrate was washed with water (3 × 3 mL), and the residue
was air-dried and found to be pure 13 on the basis of elemental
analyses.
1,3-Dimethyl-2,4,5-triiodoimidazolium Iodate (13). Tdec: 177.4
°C. IR: ν = 3264, 2933, 1669, 1560, 1501, 1473, 1432, 1384, 1313,
1093, 783, 751, 629, 548, 543, 444 cm−1. No NMR data were obtained
because of its poor solubility in DMSO. Elemental analysis of
C5H6I4N2O3 (649.73). Calcd: C, 9.24; H, 0.93; N, 4.31. Found: C,
9.02; H, 1.09; N, 4.14.
1,3-Dimethyl-4,5-diiodoimidazolium Iodate (14). Tdec: 187.0 °C.
IR: ν = 3314, 3166, 3136, 3016, 1629, 1560, 1514, 1448, 1384, 1322,
1188, 1105, 1044, 760, 616, 600, 577 cm−1. 1H NMR (DMSO-d6): δ
9.44 (1H, s, CH), 3.83 (3H, s, -CH3).
13C NMR (DMSO-d6): δ
140.73, 94.01, 38.82. Elemental analysis of C5H7I3N2O3 (649.73).
Calcd: C, 11.46; H, 1.35; N, 5.35. Found: C, 11.54; H, 1.24; N, 5.21.
1,1′-Methylenebis(4,5-diiodo-3-methyl-1H-imidazolium) Diio-
date (15). Tdec: 124.7 °C. IR: ν̃ = 3034, 1741, 1637, 1557, 1504,
1438, 1383, 314,1192, 1098, 759, 606 cm−1. 1H NMR (DMSO-d6): δ
9.92 (2H, s, CH), 6.61 (2H, s, CH2), 3.92 (6H, s, CH3).
13C NMR
(DMSO-d6): δ 63.90, 94.42, 97.56, 142.00. Elemental analysis of
C9H10I6N4O6·3H2O (1031.62). Calcd: C, 9.96; H, 1.49; N, 5.16.
Found: C, 9.98; H, 1.26; N, 4.97.
1,1′-Ethylenebis(4,5-diiodo-3-methyl-1H-imidazolium) Diiodate
(16). Tdec: 159.6 °C. IR: ν = 3105, 3003, 2952, 1638, 1548, 1506,
1447, 1359, 1324, 1209, 1186, 1102, 760, 621, 457 cm−1. 1H NMR
(DMSO-d6): δ 9.50 (1H, s, CH), 4.65 (4H, s, CH2), 3.88 (6H, s,
CH3).
13C NMR (DMSO-d6): δ 39.44, 50.94, 95.80, 141.01. Elemental
analysis of C10H12I6N4O6 (1045.65). Calcd: C, 11.49; H, 1.16; N, 5.36.
Found: C, 11.50; H, 1.17; N, 5.20.
1-Amino-3-methyl-4,5-diiodoimidazolium Iodate (17). Tdec: 148.4
°C. IR: ν = 3265, 3188, 3113, 3054, 1610, 1543, 1499, 1432, 1394,
1325, 1193, 1175, 1115, 1083, 1024, 995, 758, 638, 607, 588, 536, 460
cm−1. 1H NMR (DMSO-d6): δ 9.47 (1H, s, CH), 6.79 (2H, s, -NH2),
3.80 (3H, s, -CH3).
13C NMR (DMSO-d6): δ 57.35, 93.91, 99.42,
141.21. Elemental analysis of C4H6I3N3O3 (524.82). Calcd: C, 9.15; H,
1.15; N, 8.01. Found: C, 9.13; H, 1.07; N, 7.79.
1,3-Diamino-4,5-diiodoimidazolium Iodate (18). Tdec: 149.0 °C.
IR: ν = 3314, 3236, 3166, 3102, 3018, 1617, 1522, 1498, 1319, 1197,
1111, 965, 835, 791, 756, 632, 605, 571 cm−1. 1H NMR (DMSO-d6): δ
9.56 (1H, s, CH), 6.73 (4H, s, -NH2).
13C NMR (DMSO-d6): δ 95.35,
134.71. Elemental analysis of C3H5I3N4O3 (525.81). Calcd: C, 6.85; H,
0.96; N, 10.66. Found: C, 6.98; H, 0.88; N, 10.45.
1,3-Dimethyl-4,5-diiodoimidazolium Periodate (19). Tdec: 130.4
°C. IR: ν = 3166, 3093, 2950, 1729, 1655, 1557, 1513, 1438, 1386,
326, 1187, 1104, 858, 826, 775, 761, 598, 504 cm−1. 1H NMR
(DMSO-d6): δ 9.42 (1H, s, CH), 3.82 (6H, s, -CH3).
13C NMR
(DMSO-d6): δ 38.84, 93.55, 140.86. Elemental analysis of C5H7I3N2O4
(539.83). Calcd: C, 11.12; H, 1.31; N, 5.19. Found: C, 11.33; H, 1.29;
N, 5.05.
1,1′-Methylenebis(4,5-diiodo-3-methyl-1H-imidazolium) Diperio-
date (20). Tdec: 92.3 °C. IR: ν = 3154, 3117, 2946, 1733, 1638, 1552,
1508, 1439, 1191, 1104, 757, 616 cm−1. 1H NMR (DMSO-d6): δ 9.66
(2H, s, CH), 6.56 (2H, s, CH2), 3.91 (6H, s, CH3).
13C NMR
(DMSO-d6): δ 63.93, 94.44, 97.58, 142.01. Elemental analysis of
C9H10I6N4O8 (1063.63). Calcd: C, 10.16; H, 0.95; N, 5.27. Found: C,
9.96; H, 1.20; N, 4.91.
1,1′-Ethylenebis(4,5-diiodo-3-methyl-1H-imidazolium) Diperio-
date (21). Tdec: 109.8 °C. IR: ν = 3117, 3012, 2946, 1736, 1676,
1555, 1505, 1439, 1382, 1312, 1194, 1098, 757, 633, 604, 498 cm−1.
No NMR data were obtained because of its poor solubility in DMSO.
Elemental analysis of C10H12I6N4O8 (1077.65). Calcd: C, 11.15; H,
1.12; N, 5.20. Found: C, 11.33; H, 1.20; N, 5.10.
1-Amino-3-methyl-4,5-diiodoimidazolium Periodate (22). Tdec:
130.4 °C. IR: ν = 3262, 3157, 3118, 3054, 1630, 1544, 1500, 1438,
1193, 1115, 984, 773, 754, 620, 589 cm−1. 1H NMR (DMSO-d6): δ
9.46 (1H, s, CH), 6.79 (2H, s, -NH2), 3.79 (3H, s, -CH3).
13C NMR
(DMSO-d6): δ 57.32, 93.89, 99.42, 141.20. Elemental analysis of
C4H6I3N3O3 (540.82). Calcd: C, 8.88; H, 1.12; N, 7.77. Found: C,
9.03; H, 1.02; N, 7.31.
1,3-Diamino-4,5-diiodoimidazolium Periodate (23). Tdec: 143.1
°C. IR: ν = 3316, 3234, 3162, 3101, 3019, 1617, 1522, 1498, 1383,
1289, 1199, 1112, 962, 790, 769, 604, 570 cm−1. 1H NMR (DMSO-
d6): δ 9.58 (1H, s, CH), 6.74 (4H, s, -NH2).
13C NMR (DMSO-d6): δ
95.30, 134.70. Elemental analysis of C3H5I3N4O3 (541.81). Calcd: C,
6.65; H, 0.93; N, 10.34. Found: C, 6.75; H, 0.68; N, 10.54.
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